By Rodrigo Campos
NEW YORK (Reuters) - U.S. stocks rose on Tuesday, lifting the S&P 500 to a record high, boosted by healthcare after Actavis' acquisition of Allergan triggered bullish analyst notes.
Further support for equities came from U.S. producer prices that kept intact a trend of benign inflation and from higher homebuilder sentiment in November, while German analyst and investor sentiment advanced this month for the first time in almost a year.
Allergan
"There is more space for M&A. Companies are looking for areas to have growth," said Bruce Zaro, chief technical strategist at Bolton Global Asset Management in Boston.
Also Read
"Healthcare stocks are doing well, but not as a defensive play, and it is a positive that stock prices are strong and stocks are being used as currency," he said.
At 12:03 p.m. EST (1703 GMT) the Dow Jones industrial average <.DJI> rose 37.47 points, or 0.21 percent, to 17,685.22, the S&P 500 <.SPX> gained 8.49 points, or 0.42 percent, to 2,049.81 and the Nasdaq Composite <.IXIC> added 26.53 points, or 0.57 percent, to 4,697.53.
The S&P 500 hit yet another record high, topping at 2,050.65.
The largest decliner on the S&P was Urban Outfitters
Solar company SunEdison
Chinese solar company JA Solar Holdings
Advancing issues outnumbered declining ones on the NYSE by 1,941 to 1,031, for a 1.88-to-1 ratio on the upside; on the Nasdaq, 1,624 issues rose and 987 fell for a 1.65-to-1 ratio.
The S&P 500 was posting 61 new 52-week highs and 1 new low; the Nasdaq Composite was recording 76 new highs and 42 new lows.
(Reporting by Rodrigo Campos; Editing by Nick Zieminski)


